Literature DB >> 20306071

Effects of luminance combinations on the characteristics of the global flash multifocal electroretinogram (mfERG).

Jenny C Y Lung1, Henry H L Chan.   

Abstract

PURPOSE: This study aims to ascertain the characteristics of the response triggered by the global flash multifocal electroretinogram (MOFO mfERG) under various combinations of global and focal flash luminance, and to determine the optimal conditions for this measurement.
METHODS: Ten normal subjects with mean age 23.2 yrs (+/- 1.14 yrs) were recruited for the MOFO mfERG measurement. The visual stimulation consisted of four video frames (stimulus frame with 103 scaled hexagonal focal flashes, followed by a dark frame, a global flash and then another dark frame). The focal and global flash intensities were varied independently for four levels (50, 100, 200 and 400 cd/m(2)). The subjects then underwent measurements with sixteen combinations of focal and global flash luminance. The direct component (DC) and induced component (IC) of the MOFO mfERG were grouped into central and peripheral regions for analysis.
RESULTS: The central and peripheral DC amplitude increased with the focal flash luminance under constant global flash luminance. Moreover, the proportion of the global flash and focal flash intensity was shown to be important to achieve an optimal IC response. When the ratio of global flash luminance to focal flash luminance (g/f ratio) was kept at about 2:1, the central and peripheral IC amplitude reached the peak value, and further increasing the global flash luminance would not enhance the IC response magnitude. The implicit time of both central and peripheral DC generally decreased with the increase of g/f ratio. However, the implicit time of central and peripheral IC increased with the g/f ratio.
CONCLUSION: The g/f ratio is important in the MOFO mfERG paradigm, since the DC and IC responses change with this ratio. In order to obtain both optimal DC and IC responses, a g/f ratio of 1:1 with focal flash luminance between 100 cd/m(2) and 200 cd/m(2) would be recommended. As the global flash mfERG paradigm is studying the interaction triggered by both flashes, the g/f ratio is a vital parameter for measurement in future studies.

Entities:  

Mesh:

Year:  2010        PMID: 20306071     DOI: 10.1007/s00417-010-1346-5

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  21 in total

1.  Clinical applications of multifocal electroretinography.

Authors:  U Kretschmann; M Bock; R Gockeln; E Zrenner
Journal:  Doc Ophthalmol       Date:  2000       Impact factor: 2.379

2.  The optic nerve head component of the human ERG.

Authors:  E E Sutter; M A Bearse
Journal:  Vision Res       Date:  1999-02       Impact factor: 1.886

3.  Multifocal electroretinograms combined with periodic flashes: direct responses and induced components.

Authors:  Yoshiaki Shimada; Marcus A Bearse; Erich E Sutter
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-17       Impact factor: 3.117

4.  The 'two global flash' mfERG in high and normal tension primary open-angle glaucoma.

Authors:  Anja M Palmowski-Wolfe; Margarita G Todorova; Selim Orguel; Josef Flammer; Mitchell Brigell
Journal:  Doc Ophthalmol       Date:  2006-12-08       Impact factor: 2.379

5.  Pharmacologically defined components of the normal porcine multifocal ERG.

Authors:  Yiu-Fai Ng; Henry H L Chan; Patrick H W Chu; Andrew W Siu; Chi-Ho To; Brady A Beale; Brian C Gilger; Fulton Wong
Journal:  Doc Ophthalmol       Date:  2007-08-25       Impact factor: 2.379

6.  The association between multifocal electroretinograms and OCT retinal thickness in retinitis pigmentosa patients with good visual acuity.

Authors:  C J Wolsley; G Silvestri; J O'Neill; K J Saunders; R S Anderson
Journal:  Eye (Lond)       Date:  2008-10-31       Impact factor: 3.775

7.  Decreased nasal-temporal asymmetry of the second-order kernel response of multifocal electroretinograms in eyes with normal-tension glaucoma.

Authors:  Eijiro Asano; Kiyofumi Mochizuki; Akira Sawada; Ei-Ichiro Nagasaka; Yuji Kondo; Tetsuya Yamamoto
Journal:  Jpn J Ophthalmol       Date:  2007-10-05       Impact factor: 2.447

8.  Slow-stimulated multifocal ERG in high- and normal-tension glaucoma.

Authors:  Anja M Palmowski-Wolfe; Reiner J Allgayer; Bernhild Vernaleken; Andy Schötzau; Klaus W Ruprecht
Journal:  Doc Ophthalmol       Date:  2006-06-19       Impact factor: 2.379

9.  Investigation of retinitis pigmentosa using the multifocal electroretinogram.

Authors:  H L Chan; B Brown
Journal:  Ophthalmic Physiol Opt       Date:  1998-07       Impact factor: 3.117

10.  Long-term follow-up of retinitis pigmentosa patients with multifocal electroretinography.

Authors:  Ditta Nagy; Birgitt Schönfisch; Eberhart Zrenner; Herbert Jägle
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-19       Impact factor: 4.799

View more
  4 in total

1.  Global flash multifocal electroretinogram: early detection of local functional changes and its correlations with optical coherence tomography and visual field tests in diabetic eyes.

Authors:  J C Y Lung; P G Swann; D S H Wong; H H L Chan
Journal:  Doc Ophthalmol       Date:  2012-07-25       Impact factor: 2.379

2.  Loss of the low-frequency component of the global-flash multifocal electroretinogram in primate eyes with experimental glaucoma.

Authors:  Xunda Luo; Nimesh B Patel; Ronald S Harwerth; Laura J Frishman
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-01       Impact factor: 4.799

3.  Early local functional changes in the human diabetic retina: a global flash multifocal electroretinogram study.

Authors:  Jenny C Y Lung; Peter G Swann; Henry H L Chan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-04-12       Impact factor: 3.117

4.  Human electroretinal responses to grating patterns and defocus changes by global flash multifocal electroretinogram.

Authors:  Man Pan Chin; Patrick H W Chu; Allen M Y Cheong; Henry H L Chan
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.